Breathe better naturally: Goodair Nosebuds

Goodair is rethinking nasal congestion treatment with an innovative, drug-free solution that harnesses the body’s natural defenses to clear airways and enhance wellbeing.

Developed from research conducted by Dr David White at Auckland University of Technology (AUT), the groundbreaking Goodair Nosebuds offer a new approach to improving overall well-being.

The small, portable device—inspired by leading-edge science and traditional yoga breathing techniques—delivers a soothing hum, stimulating your airways to naturally clear mucus and pathogens. Clinically tested, just 20 minutes of regular use of the Nosebuds can improve airway clarity, balance hydration, and enhance overall well-being.

With one-third of the population suffering from nasal congestion, Goodair Nosebuds provide a drug-free alternative for those seeking relief from this widespread issue.

AUT Ventures led the commercialisation of the project (then called Kazoo-NO), securing PreSeed Accelerator Funding to further develop the device, conduct consumer validation trials and perform patient studies to assess its efficacy and ease of use.

The technology was licensed by AUT Ventures to My Better Breathing (trading as Goodair), which has gone on to raise $1.75 million of investment to establish the company, build the team, develop the product and prepare for launch.

The Goodair team has expanded to seven members, all dedicated to advancing respiratory health. They're now focused on bringing the Nosebuds to market in early 2025.

Powered by PreSeed